Celerion adds biometric fingerprint tech across units

By Melissa Fassbender

- Last updated on GMT

Celerion adds biometric fingerprint tech across units

Related tags Clinical trial

Celerion has implemented Verified Clinical Trials’ (VCT) biometric fingerprint technology to address “significant amount” of participants dual enrolling at Ph I units.

All of Celerion's units now use VCT’s biometric verification system, which prevents dual enrollment in clinical trials.

Biometrics is considered the most effective and safe method for identifying participants. It is very difficult to falsify​,” said Phil Bach, Vice President, Global Clinical Research at Celerion, who told us the fingerprint biometric devices were added “for accuracy and speed​.”

According to Bach, Celerion has been able to improve patient safety and preset data integrity in clinical research trials by using VCT.

Bach described the registry as “an invaluable tool​” that has prevented participants enrolled at other Phase I centers from enrolling simultaneously in trials at Celerion units, “thus preventing a potential safety risk to the participants​.” 

There has been a significant amount of participants attempting to dual enroll in Phase I and Phase II/III clinical trials that have been stopped by the Verified Clinical Trials system​,” Bach added. Up to 25% of clinical research participants attempt multiple simultaneous clinical trial enrollment or other protocol violations at Phase I units, he noted.

The incidence ranges from 2% to 12% in Phase II-IV clinical trials depending upon the therapeutic indication​,” Bach said – which poses potential risks to the research participant, the site, and sponsor.

It only takes but a few severe complications to cause a possible hold on approval of a study compound, or more importantly, a serious health issue for a participant​.”

(Feature image: istock/maxkabakov)

Related news

Show more

Related products

show more

The Right CDMO Can Unlock Faster Drug Development

The Right CDMO Can Unlock Faster Drug Development

Content provided by Lonza Small Molecules | 15-May-2023 | Interview

Drug development presents biotech companies with ever-changing challenges. Enabling a faster end-to-end process requires seamless flexibility and extensive...

SDTM supplemental qualifiers explained

SDTM supplemental qualifiers explained

Content provided by Formedix | 12-May-2023 | White Paper

What are SDTM supplemental qualifiers? In short, these are variables in non-CDISC datasets that cannot be mapped to a variable that matches the SDTM standard....

How clinical trial software can optimize trials

How clinical trial software can optimize trials

Content provided by Formedix | 17-Apr-2023 | White Paper

Companies often have to conduct multiple clinical trials at the same time, which means they've got to be efficient, and compliant with industry regulations....

Related suppliers

Follow us


View more